Top compounds associated with response to TTLL6


Feature Type Standardized
Nominal ANOVA
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA etomoxir CTRPv2 pan-cancer AAC 0.013 0.7
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Ko-143 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA L-685458 CCLE pan-cancer AAC 0.016 0.7
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.017 0.7
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.028 0.7
Download CSV